Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome (Q34466871)

2 August 2017

1 reference

title

Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome (English)

1 reference

2 August 2017

3

Veldhuis JD

1 reference

2 August 2017

Barontini M

1

1 reference

2 August 2017

García-Rudaz MC

series ordinal

2

1 reference

2 August 2017

publication date

1 November 2001

1 reference

Archives of Medical Research

2 August 2017

published in

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

544-552

1 reference

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Neuroendocrine aspects of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Endocrinologic features of oligomenorrheic adolescent girls

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Serum steroids and pituitary hormones in female puberty: a partly longitudinal study

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Puberty decreases insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

RELATIONSHIP BETWEEN THE PUBERTAL FALL INSEX HORMONE BINDING GLOBULIN AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-I. A SYNCHRONIZED APPROACH TO PUBERTAL DEVELOPMENT?

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Free Insulin-Like Growth Factor I Serum Levels in 1430 Healthy Children and Adults, and Its Diagnostic Value in Patients Suspected of Growth Hormone Deficiency

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Gonadotropin Levels and Secretory Patterns in Patients with Typical and Atypical Polycystic Ovarian Disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Effects of alpha 1-adrenergic blockade on pulsatile luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

High concentrations of catecholamines in human hypothalamic-hypophysial blood

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Evidence for altered catecholamine metabolism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Norepinephrine amplifies human chorionic gonadotropin-stimulated androgen biosynthesis by ovarian theca-interstitial cells

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Adrenergic regulation of ovarian androgen biosynthesis is mediated via beta 2-adrenergic theca-interstitial cell recognition sites

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Effects of dopamine and metoclopramide in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Effects on plasma luteinizing hormone and follicle-stimulating hormone of varying the frequency and amplitude of gonadotropin-releasing hormone pulses in ovariectomized ewes with hypothalamo-pituitary disconnection

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Gonadotropin-releasing hormone-dependent regulation of gonadotropin subunit messenger ribonucleic acid levels in the rat

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Follistatin and activin: a potential intrinsic regulatory system within diverse tissues

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Pituitary content of gonadotropins and receptors for gonadotropin-releasing hormone (GnRH) and hypothalamic content of GnRH during the periovulatory period of the ewe.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Estradiol augmentation of pituitary responsiveness to gonadotropin-releasing hormone in women.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Modulation of pituitary gonadotropin response to gonadotropin-releasing hormone by estradiol

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Strength-Duration Characteristics of Estrogen Effects on Gonadotropin Response to Gonadotropin-Releasing Hormone in Women. I. Effects of Varying Duration of Estradiol Administration

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Resistance of Gonadotropin Releasing Hormone Drive to Sex Steroid-Induced Suppression in Hyperandrogenic Anovulation1

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone1

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Disruption of the joint synchrony of luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Approximate entropy as a measure of system complexity

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Randomness and degrees of irregularity

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Orderliness of hormone release patterns: a complementary measure to conventional pulsatile and circadian analyses

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immune ratio of LH in healthy women and in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Modulation of serum and pituitary luteinizing hormone bioactivity by androgen in the rat

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The effects of ovariectomy, estrogen replacement, and neuraminidase treatment on the properties of the adenohypophysial glycoprotein hormones of the Rhesus monkey

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

An in vitro study of LH release, synthesis and heterogeneity in pituitaries from proestrous and short-term ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Endogenous opiates participate in the regulation of pulsatile luteinizing hormone release in an unopposed estrogen milieu: studies in estrogen-replaced, gonadectomized patients with testicular feminization.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Estrogen regulates the gonadotropin-releasing hormone-stimulated secretion of biologically active luteinizing hormone

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Primary gonadal failure in men selectively amplifies the mass of follicle stimulating hormone (FSH) secreted per burst and increases the disorderliness of FSH release patterns: reversibility with testosterone replacement

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Greater signal regularity may indicate increased system isolation.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Neuroendocrine aberrations in women with functional hypothalamic amenorrhea

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca.

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

The Impact of Insulin Secretion on the Ovarian Response to Exogenous Gonadotropins in Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17alpha-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells

1 reference

https://api.crossref.org/works/10.1016/S0188-4409(01)00325-3

7 January 2021

10.1016/S0188-4409(01)00325-3

Identifiers

DOI

1 reference

2 August 2017

1 reference